Legacy Wealth Management LLC MS Purchases 5,425 Shares of Danaher Corporation $DHR

Key Points

• Legacy Wealth Management LLC MS increased its holdings in Danaher Corporation by 40.7%, purchasing an additional 5,425 shares, bringing their total ownership to 18,770 shares valued at approximately $3.7 million.
• Danaher reported $1.80 earnings per share for the last quarter, exceeding analysts' expectations, with a revenue of $5.94 billion—up 3.4% from the previous year.
• The company recently announced a quarterly dividend of $0.32 per share, with a payout ratio of 27.23% and a dividend yield of 0.7%.

Legacy Wealth Management LLC MS lifted its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 40.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,770 shares of the conglomerate's stock after purchasing an additional 5,425 shares during the period. Danaher accounts for about 1.1% of Legacy Wealth Management LLC MS's holdings, making the stock its 20th biggest position. Legacy Wealth Management LLC MS's holdings in Danaher were worth $3,708,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in DHR. GHP Investment Advisors Inc. lifted its position in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares in the last quarter. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter valued at about $27,000. Sierra Ocean LLC lifted its position in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher during the first quarter valued at about $31,000. Finally, Dunhill Financial LLC lifted its position in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 67 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

DHR opened at $190.07 on Friday. The company has a market capitalization of $136.10 billion, a price-to-earnings ratio of 40.44, a PEG ratio of 2.72 and a beta of 0.75. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $201.21 and a 200-day moving average price of $198.90. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue was up 3.4% on a year-over-year basis. During the same quarter last year, the company earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. Danaher's dividend payout ratio (DPR) is presently 27.23%.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on DHR shares. Evercore ISI dropped their price target on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective for the company in a report on Friday, July 11th. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a report on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Finally, Robert W. Baird raised their price objective on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, Danaher has a consensus rating of "Moderate Buy" and an average price target of $246.35.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.